These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3676670)

  • 1. Bladder cancer flow cytometry profiles in relation to histological grade and stage.
    Hadjissotiriou GG; Green DK; Smith G; McIntyre MA; Hargreave TB; Chisholm GD
    Br J Urol; 1987 Sep; 60(3):239-47. PubMed ID: 3676670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic value of flow cytometry of bladder lavage in the surveillance of bladder tumors].
    Hijazi A; Devonec M; Muchada E; Dubernard JM; Revillard JP
    J Urol (Paris); 1987; 93(1):11-20. PubMed ID: 3559255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of bromodeoxyuridine high labeled bladder cancer measured by flow cytometry: does flow cytometric determination predict the prognosis of patients with transitional cell carcinoma of the bladder.
    Tachibana M; Deguchi N; Baba S; Jitsukawa S; Hata M; Tazaki H
    J Urol; 1993 Apr; 149(4):739-43. PubMed ID: 8455234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [DNA profile, recurrence rate and progression of superficial G2 cancer of the urinary bladder].
    Maier G; Heissler HE; Blech M; Schröter W
    Urologe A; 1988 May; 27(3):173-6. PubMed ID: 3407050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical application of flow cytometry in urology. 2. Comparison between bladder biopsy specimens and bladder irrigation samples by flow cytometric DNA-histogram].
    Tachibana M; Nakamura S; Shibayama T; Jitsukawa S; Deguchi N; Baba S; Nakazono M; Hata M; Tazaki H
    Nihon Hinyokika Gakkai Zasshi; 1986 Nov; 77(11):1857-63. PubMed ID: 3573469
    [No Abstract]   [Full Text] [Related]  

  • 6. Flow cytometric analysis of primary adenocarcinoma of the bladder.
    Badalament RA; Cibas ES; Reuter VE; Fair WR; Melamed MR
    J Urol; 1987 Jun; 137(6):1159-62. PubMed ID: 3586147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis in bladder cancer. A study of cytometric, morphometric and immunohistochemical techniques.
    Vaskó J
    Scand J Urol Nephrol Suppl; 1994; 160():1-73. PubMed ID: 7529427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometry of deparaffinized nuclei compared to histological grading for the pathological evaluation of transitional cell carcinomas.
    Murphy WM; Chandler RW; Trafford RM
    J Urol; 1986 Apr; 135(4):694-7. PubMed ID: 3959188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of early dynamic and delayed post-diuretic
    Sharma A; Mete UK; Sood A; Kakkar N; Gorla AK; Mittal BR
    Br J Radiol; 2017 Apr; 90(1072):20160787. PubMed ID: 28256904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of ploidy level in bladder tumors and selected site specimens by flow cytometry.
    Jakobsen A; Mommsen S; Olsen S
    Cytometry; 1983 Sep; 4(2):170-3. PubMed ID: 6628139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative flow cytometric deoxyribonucleic acid studies on exophytic tumor and random mucosal biopsies in untreated carcinoma of the bladder.
    Norming U; Nyman CR; Tribukait B
    J Urol; 1989 Dec; 142(6):1442-7. PubMed ID: 2585616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression and survival in transitional cell bladder cancer: a comparison of established prognostic factors, S-phase fraction and DNA ploidy.
    Lipponen PK; Eskelinen MJ; Nordling S
    Eur J Cancer; 1991; 27(7):877-81. PubMed ID: 1834120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective study of prognostic importance of DNA flow cytometry of urinary bladder carcinoma.
    Blomjous CE; Schipper NW; Baak JP; van Galen EM; de Voogt HJ; Meyer CJ
    J Clin Pathol; 1988 Jan; 41(1):21-5. PubMed ID: 3343376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of morphometry and DNA flow cytometry with standard prognostic factors in bladder cancer.
    Lipponen PK; Collan Y; Eskelinen MJ; Pesonen E; Sotarauta M; Nordling S
    Br J Urol; 1990 Jun; 65(6):589-97. PubMed ID: 2372672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urothelial tumours of the urinary bladder: a histopathological study of cystoscopic biopsies.
    Vaidya S; Lakhey M; K C S; Hirachand S
    JNMA J Nepal Med Assoc; 2013; 52(191):475-8. PubMed ID: 24907954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of flow cytometric DNA analysis of bladder washings in patients with bladder cancers].
    Tachibana M; Baba S; Deguchi N; Jitsukawa S; Hata M; Tazaki H
    Nihon Hinyokika Gakkai Zasshi; 1988 Aug; 79(8):1413-7. PubMed ID: 3246827
    [No Abstract]   [Full Text] [Related]  

  • 17. Multivariate analysis of flow cytometric deoxyribonucleic acid parameters and histological features for prognosis of bladder cancer patients.
    Tachibana M; Deguchi N; Baba S; Jitsukawa S; Hata M; Tazaki H
    J Urol; 1991 Dec; 146(6):1530-4. PubMed ID: 1942334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stage T1 tumor of the bladder. From research to prognosis].
    Albert P; Leremboure H; Hernandez F; Coulange C; Rampal M
    Ann Urol (Paris); 1988; 22(4):255-61. PubMed ID: 3056232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ta and T1 bladder cancer: location, recurrence and progression.
    Heney NM; Nocks BN; Daly JJ; Prout GR; Newall JB; Griffin PP; Perrone TL; Szyfelbein WA
    Br J Urol; 1982 Apr; 54(2):152-7. PubMed ID: 7082932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of cell deoxyribonucleic acid content measured by flow cytometry in bladder cancer.
    Bittard H; Lamy B; Billery C
    J Urol; 1996 Jun; 155(6):1887-91. PubMed ID: 8618280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.